397 related articles for article (PubMed ID: 7212800)
1. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
2. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
3. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
4. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
5. Judging the therapeutic value of lymph node dissections for melanoma.
Chan AD; Essner R; Wanek LA; Morton DL
J Am Coll Surg; 2000 Jul; 191(1):16-22; discussion 22-3. PubMed ID: 10898179
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of regional lymph nodes in cutaneous melanoma.
Balch CM
J Am Acad Dermatol; 1980 Nov; 3(5):511-24. PubMed ID: 7217379
[TBL] [Abstract][Full Text] [Related]
7. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
[TBL] [Abstract][Full Text] [Related]
8. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
9. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
10. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
Balch CM; Soong SJ; Bartolucci AA; Urist MM; Karakousis CP; Smith TJ; Temple WJ; Ross MI; Jewell WR; Mihm MC; Barnhill RL; Wanebo HJ
Ann Surg; 1996 Sep; 224(3):255-63; discussion 263-6. PubMed ID: 8813254
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based staging system for cutaneous melanoma.
Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of thick cutaneous melanoma.
Kim SH; Garcia C; Rodriguez J; Coit DG
J Am Coll Surg; 1999 Mar; 188(3):241-7. PubMed ID: 10065812
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.
Weide B; Faller C; Büttner P; Pflugfelder A; Leiter U; Eigentler TK; Bauer J; Forschner A; Meier F; Garbe C
PLoS One; 2013; 8(4):e63137. PubMed ID: 23638183
[TBL] [Abstract][Full Text] [Related]
15. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
16. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.
Buzaid AC; Tinoco LA; Jendiroba D; Tu ZN; Lee JJ; Legha SS; Ross MI; Balch CM; Benjamin RS
J Clin Oncol; 1995 Sep; 13(9):2361-8. PubMed ID: 7666095
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease.
Berdeaux DH; Meyskens FL; Parks B; Tong T; Loescher L; Moon TE
Cancer; 1989 Apr; 63(7):1430-6. PubMed ID: 2920369
[TBL] [Abstract][Full Text] [Related]
20. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
